Celebrating its ninth year, the Biomarkers & Precision Medicine US conference is a premier, immersive event dedicated to highlighting the latest trends, essential tools, and innovative research in the field of biomarker discovery. The agenda for this year expands its focus to include dedicated programs covering Spatial Biology for Precision Medicine and Digital Pathology & AI, reflecting the rapid evolution of diagnostic and therapeutic technologies. This meeting provides a crucial platform for professionals to deepen their understanding of how these advanced areas are influencing modern healthcare.

The conference serves as a central gathering point for leading experts drawn from global pharmaceutical companies, pioneering biotech firms, innovative startups, and key academic and healthcare institutions. These participants contribute valuable insights across various therapeutic areas, covering every stage of the drug development lifecycle, from early clinical trials to the creation of precise patient treatments. The collective aim is to foster collaboration and accelerate the implementation of next-generation precision medicine solutions.